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persisted for 6 months 16 (CPTE Group); and (3) PTE that was neither APTE nor CPTE. The diagnosis of CPTE in our registry was from right-heart catheterization and pulmonary angiography as the principal requirement. Patients with a strong clinical suspicion of CPTE but without results from right-heart catheterization or pulmonary angiography were included in the present study if they had persistently increased right ventricular afterload observed on ECG (eg, S waves in lead I combined with Q waves in lead III or negative T waves in the precordal leads V1-3) 17 and echocardiography (eg, right ventricular dilatation or hypertrophy, paradoxical septal wall motion, or tricuspid regargitation jet >2.8 m/s). All decisions concerning the diagnostic workup were made by the clinicians caring for each the patient.
Data Collection
Complete information on the clinical course of the enrolled patients was obtained from a standardized questionnaire sent to the participating clinical centers from the steering committee. Clinical symptoms and signs of the patients at diagnosis, presence of underlying diseases or predisposing factors for venous thromboembolism, diagnostic procedures and presence of deep venous thrombosis were recorded.
Statistical Analysis
Statistical analysis was performed on the incidence and clinical characteristics of APTE/CPTE in the APTE and CPTE groups only. All continuous variables were reported as mean ± standard deviation. Comparisons of proportion were made using chi-square test, or Fisher's exact test when appropriate. Difference in the mean age between the APTE and CPTE groups was examined using an unpaired Student's t test. All significance tests were 2-tailed, with p<0.05 considered to show statistical significance.
Results
Based on the clinical course, 309 patients (187 women, 122 men) were classified into the APTE group, and 68 (46 women, 22 men) into the CPTE group. The ratio of the incidence of CPTE to APTE during the study period was 0.22 (the incidence of APTE and CPTE by age is shown in Fig 1) . The mean age at diagnosis was 62±16 years (range, 17-92 years) in the CPTE group and 60±15 years (range, 15-87 years) in the APTE group. The female/male ratio in the CPTE group was 2.1 and 1.5 in the APTE group. There was no significant difference in age or sex between the 2 groups. Table 1 shows the frequency of each method used for the diagnosis of CPTE. Table 2 shows the clinical characteristics at diagnosis. Although most of the patients (78%) had progressive exertional dyspnea, not many other symptoms were observed. The predisposing factors for venous thromboembolism, including a recent major operation, a recent major trauma or fracture, malignancy, prolonged immobilization and obesity, were more frequently observed in the APTE group than in the CPTE group. On the other hand, thrombophilia was more frequently seen in the CPTE group (8 patients with lupus anticoagulant, 2 with protein C deficiency and 1 with antithrombin III deficiency). These predisposing factors, other than thrombophilia, were only seen in isolated cases of CPTE; there was no significant difference between the APTE and CPTE groups in the history of deep venous thrombosis (32% vs 38%).
Discussion
In a minority of survivors of embolism, the embolic event, which is commonly not diagnosed during its acute phase, will result in organized and recanalized residura. If the obstruction is of sufficient magnitude to substantially increase right ventricular afterload, CPTE will ensue. 2 The failure of normal embolic resolution remains one of the most intriguing questions in the pathogenesis of CPTE. The only identified thrombotic predisposition is reported to be the presence of lupus anticoagulant; approximately 10% in one report 18 and 12% in the present study. Less than 1% of patients have deficiencies of antithrombin III, protein C or protein S. 1 Given the annual incidence of PTE in the United States, it is likely that only 0.1-0.5% of patients suffering an acute embolic event (ie, 500-2,500 patients per year) will develop CPTE. 19, 20 However, in the present study, the total number of CPTE patients was 22% of the number of APTE patients, which is a much higher percentage than seen in the United States. A similar finding has been demonstrated in a local study. 11 There are several reasons for this inconsistency between the US reports and ours. The first is the difference in the mechanism of CPTE development between Japanese and Western patients. There may not be a relationship between APTE and CPTE in most cases in Japan, an hypothesis that can be supported by results obtained from the present study. There was a significant difference in the predisposing factors for venous thromboembolism between the CPTE and APTE groups. The ratio of females to males in the CPTE group was higher (2.1) than that in the study conducted in the United States (ratio: 0.7), 21 whereas the male/female ratio in the general Japanese population is 1.04. Although it had been suggested that the main cause of CPTE is deep venous thrombi that repeatedly detach and cause chronic thrombosis in the pulmonary artery, 20 the demonstrated incidence of deep venous thrombosis associated with CPTE was not high: 38% of the present patients had deep venous thrombosis.
The second possible reason for the inconsistency could be that the frequency of diagnosing APTE correctly is extremely low in Japan. Although a recent autopsy study indicates that the incidence of APTE in Japan is comparable to that of Western countries, 22 according to a 1999 report the clinical diagnosis of APTE in Japan is approximately 200-fold less than the rate in the United States. 23 Therefore, the actual incidence of APTE might be higher than the observed incidence. However, if the ratio of CPTE to APTE was as low as that in the United States (0.1-0.5%), APTE would have been observed in 13,600-68,000 patients in the participating clinical centers during the study period. These calculated values are not reliable.
The third possible reason was the potential inclusion of patients with pulmonary vasculitis caused by autoimmune diseases. For instance, Takayasu's arteritis often shows defects on lung scintigraphy and pulmonary angiogram and is clinically difficult to discriminate from CPTE. 24, 25 
Study Limitations
We did not have definite criteria for CPTE and, in addition, we included patients with clinically suspected CPTE but without right-heart catheterization or pulmonary angiography results. Thus, our registry might include other pulmonary vessel diseases. However, because there have been few cases diagnosed with CPTE, there has not been rigorous definition and discussion of the pathogenesis of CPTE in Japan. Consequently, the cases of CPTE diagnosed in past years might include different diseases. Furthermore, there are 2 concepts of CPTE: (1) PTE with a chronically unresolved thrombus in pulmonary artery, and (2) PTE with chronic pulmonary hypertension caused by an organized thrombus. In this study, we categorized PTE with chronic pulmonary hypertension into the CPTE group. Further investigation of CPTE with a precise definition is necessary to ascertain the reliability of our results.
When pulmonary thromboendarterectomy is not possible, the only curative therapy is lung transplantation. Organ transplant has recently become available as a treatment option in Japan, which makes it imperative to clarify the pathophysiology of CPTE in Japan so that lung transplantation for patients with CPTE can be considered as soon as possible.
Conclusions
The present study was conducted to investigate the incidence and clinical characteristics of patients with CPTE in Japan. There were some differences in the clinical characteristics of CPTE between Japanese and American patients, which suggests that the pathogenesis of CPTE in Japan may differ from that in the United States.
